A preclinical study published in Nature Biomedical Engineering describes a synthetic biology approach that converts the physical softness of cancer cells into a targetable signal for CAR-T ...
Mayo Clinic researchers have used AI to screen nearly 40,000 compounds and identify a small molecule inhibitor targeting ...
Professor Joseph C. Wu of Stanford University explains how stem cells, human-relevant models and AI are helping researchers ...
A modular tissue-chip platform incorporating ultrathin human cell membranes and real-time sensors has been accepted into the FDA’s ISTAND pilot programme, marking a significant regulatory step towards ...
The departure of leading AI researchers from Google to found Discovery Loop raises important questions about the future ...
Scientists have used artificial intelligence to design complete, functional bacteriophage genomes from scratch, with engineered phages capable of overcoming resistance in bacteria that had defeated ...
Insilico Medicine has nominated ISM9077, an AI-designed small molecule targeting pathological inflammation, as its 32nd preclinical candidate since 2021, with potential applications across dry AMD, ...
Voyager Therapeutics has presented six-month GLP toxicology data for VY1706, its investigational tau-targeting gene therapy, ...
Oblenio Bio has dosed the first patients in a Phase 1a trial of LBL-051, a tri-specific T cell engager designed to ...
A small molecule inhibitor developed at Virginia Commonwealth University has demonstrated the ability to eliminate cancer ...
A new gene therapy platform exploiting the brain's glymphatic transport system and engineered AAV5 vectors could offer a ...
Researchers at Texas A&M have developed AI-driven platforms to help scientists navigate the bottlenecks of tuberculosis drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results